Drug
Forodesine clinical trials
Includes 10 studies of Forodesine hydrochloride.
- studies test it
- 14
- open now
- 0
- in phase 3
- 0
- first study started
- 2001
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
14 studies that test it; most in 2004 (3)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 10
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
BioCryst Pharmaceuticals (10) · Mundipharma K.K. (2) · Mundipharma Research Limited (2)
Studies
Open first, then newest update. How each study uses forodesine is read from its arms, and is right about nine times in ten.
Testing it · 14
- Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma PatientsCompletedPhase 1/2Mundipharma K.K.NCT01776411Written as forodesine hydrochloride
- Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell MalignanciesCompletedPhase 1Mundipharma K.K.NCT00823355Written as forodesine hydrochloride
- Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell LymphomaCompletedPhase 1BioCryst PharmaceuticalsNCT00098332Written as forodesine hydrochloride
- BCX-1777 in Treating Patients With Refractory CancerCompletedPhase 1BioCryst PharmaceuticalsNCT00073944Written as forodesine hydrochloride
- BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell LymphomaCompletedPhase 1/2BioCryst PharmaceuticalsNCT00061880Written as forodesine hydrochloride
- Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.TerminatedPhase 1/2Mundipharma Research LimitedNCT00742495Written as Forodesine
- Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)CompletedPhase 2BioCryst PharmaceuticalsNCT00289549Written as forodesine hydrochloride (BCX-1777)
- Forodesine in the Treatment of Cutaneous T-Cell LymphomaCompletedPhase 2BioCryst PharmaceuticalsNCT00501735Written as Forodesine 200 mg
- Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)CompletedPhase 2BioCryst PharmaceuticalsNCT00640523Written as forodesine HCl
- Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment RegimensTerminatedPhase 2BioCryst PharmaceuticalsNCT00419081Written as Forodesine Hydrochloride Capsules (100 mg)
- Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic LeukemiaCompletedPhase 1/2BioCryst PharmaceuticalsNCT00289562Written as forodesine hydrochloride (BCX-1777)
- Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell LeukemiaCompletedPhase 2BioCryst PharmaceuticalsNCT00095381Written as forodesine hydrochloride (BCX-1777)
- Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic LeukemiaTerminatedPhase 1Mundipharma Research LimitedNCT00646165Written as Forodesine
- Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or LymphomasCompletedPhase 1/2BioCryst PharmaceuticalsNCT00035022Written as BCX-1777
Codes
What other systems call forodesine · ClinicalTrials.gg INT004086
- MeSH (NLM) C113101forodesineOne source NLM
- UNII (FDA) 426X066ELKFORODESINEConfirmed FDA, NLM, Wikidata
- Wikidata Q410040forodesineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65755ForodesineOne source FDA
- DrugBank DB06185One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C113101 | forodesine | One source NLM |
| UNII (FDA) | 426X066ELK | FORODESINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q410040 | forodesine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65755 | Forodesine | One source FDA |
| DrugBank | DB06185 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.